Formation of cyclophosphamide specific DNA adducts in hematological diseases - Wikidata - awgldk - TriplyDB

Formation of cyclophosphamide specific DNA adducts in hematological diseases

Formation of cyclophosphamide specific DNA adducts in hematological diseases

http://www.wikidata.org/entity/Q35478775

about

Advances in understanding the complex mechanisms of DNA interstrand cross-link repair Chemical Biology of N5-Substituted Formamidopyrimidine DNA Adducts.Quantitation of DNA adducts by stable isotope dilution mass spectrometry.Mass spectrometry of structurally modified DNA.DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells.Severe Myelotoxicity Associated with Thiopurine S-Methyltransferase*3A/*3C Polymorphisms in a Patient with Pediatric Leukemia and the Effect of Steroid Therapy.A quantitative PCR-based assay reveals that nucleotide excision repair plays a predominant role in the removal of DNA-protein crosslinks from plasmids transfected into mammalian cells.

P2860

Q28299636-F29ECF77-1B0A-4A1A-836B-F2A2F2370AB8 Q33649473-24D92668-4405-4CE9-960A-5C05E4A30E9A Q36390390-6E660289-A7A8-465B-BD1F-312AB09AE6C2 Q36979806-1DB3AF0C-B370-4A18-ABC5-A24790F8CFE2 Q37736567-CDB3A078-C5E6-4D40-835A-2852F21A245F Q39007207-4CD6CB0E-205B-4A81-A0C3-7FBAFE0F9C36 Q42129264-80577A3C-498D-4B4D-A98F-B7D89DC5201D Q50056219-8E321F27-B337-419C-8E9E-DE9D64BE3401

P2860

Formation of cyclophosphamide specific DNA adducts in hematological diseases

http://www.wikidata.org/entity/Q35478775

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@ast

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@en

type

label

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@ast

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@en

prefLabel

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@ast

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@en

P1433

Q35478775-F06AA905-D619-4C39-8F58-FBD17C30A5C4

P1476

Q35478775-29EE2D09-B9E2-43AD-B120-2D728904E406

P2093

Q35478775-040378DD-2CDC-45A3-99BB-79E5831DC924

Q35478775-5622D838-0977-4A1A-8011-543E4304943F

Q35478775-97B0FC4C-C39B-40B0-B9EA-0268E53C5851

Q35478775-A4CA5BCC-E46C-412C-BC12-E447BB2BA4EC

Q35478775-B04B731C-758F-411C-B5E7-EB9760053C38

Q35478775-BD655BEF-83C5-473E-8267-D7BD9B8A37A6

Q35478775-F6A93298-AB9E-4D31-8715-BFA6E9F1383A

P2860

Q35478775-11C938C8-071E-4831-9088-219A29E785F2

Q35478775-1FB9F2CF-ED2C-4858-AAAA-75A8DC48608F

Q35478775-38CF4DBA-E071-477E-BAA0-F48733F0DBB3

Q35478775-458C19EC-2B25-4CF4-A7C9-715DDDF41BD8

Q35478775-4693720A-AC43-4A46-8A68-C716565D3155

Q35478775-48419831-8EE1-4763-B63F-87CB59571A08

Q35478775-4C21894D-5378-4D54-B79D-EA2AC39FDFE8

Q35478775-553C94CD-7F74-44AF-84BA-F5D5FE3C40A5

Q35478775-6502CBC6-3387-439A-96E4-92DE14BD1803

Q35478775-6E365499-04AB-4AA3-BB0C-E4BAA045617F

P304

Q35478775-2CE4A26B-6057-48F8-88BE-B5DEE96E2726

P31

Q35478775-9EAEB600-7C6C-4A9D-A970-C7C268EC531D

P356

Q35478775-EA025DCC-3EA3-4810-8F17-D63BD88797D6

P433

Q35478775-F03C722C-A432-4881-BB1B-AA3E78900515

P478

Q35478775-BD76CD05-E5CC-4ECF-894E-4A8BD4B0D684

P577

Q35478775-AF1FF454-8C37-4933-886E-34C650C6F5A3

P5875

Q35478775-D726D73E-9F08-4752-A186-403CF04D6F74

P698

Q35478775-49747ECF-E9FE-44DD-992D-6D6C5E81A344

P932

Q35478775-7D649EE8-DAC8-4457-B5B3-C235991E933D

P356

P1433

Pediatric Blood & Cancer

P1476

Formation of cyclophosphamide specific DNA adducts in hematological diseases

@en

P2093

Bhaskar Malayappan

http://www.w3.org/2001/XMLSchema#string

Colin Campbell

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

L'Aurelle A Johnson

http://www.w3.org/2001/XMLSchema#string

Margaret L MacMillan

http://www.w3.org/2001/XMLSchema#string

Natalia Tretyakova

http://www.w3.org/2001/XMLSchema#string

Pamala A Jacobson

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative stress-related mechanisms are associated with xenobiotics exerting excess toxicity to Fanconi anemia cells.

In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.

The Fanconi anaemia/BRCA pathway

Mouse models of Fanconi anemia

Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks

Fanconi anemia and DNA repair.

Functional defects in the fanconi anemia pathway in pancreatic cancer cells.

Fanconi anaemia proteins: major roles in cell protection against oxidative damage.

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients

HSCT for Fanconi anemia in children: factors that influence early and late results.

P304

708-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.23254

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51524889

http://www.w3.org/2001/XMLSchema#string

P698

21793181

http://www.w3.org/2001/XMLSchema#string

P932

3204332

http://www.w3.org/2001/XMLSchema#string